| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:471771271:1632 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:471771271:1632?format=raw |
LEADER: 01632cam a2200397 a 4500
001 3923737
005 20221027002242.0
008 860210s1983 ne a b 101 0 eng
010 $a 83176056
020 $a9021995832
020 $a0444903216 (Elsevier)
035 $a(OCoLC)9974720
035 $a(OCoLC)ocm09974720
035 $a(CStRLIN)NYCM86-B414
035 $9ADH6308HS
035 $a(NNC)3923737
035 $a3923737
040 $dCStRLIN$dNNC-M
041 0 $aeng$bdutfregerspa
050 00 $aRM666.A49$bA92 1983
082 0 $a615/.32923$219
245 00 $aAugmentin, clavulanate-potentiated amoxycillin :$bproceedings of the European symposium, Scheveningen, the Netherlands, 28-29 June, 1982 /$ceditors, E.A.P. Croydon and M.F. Michel.
260 $aAmsterdam :$bExcerpta Medica,$c1983.
300 $axi, 366 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent clinical practice series ;$v4
520 $aSummaries in Dutch, French, German, and Spanish.
504 $aIncludes bibliographical references and index.
650 2 $aAmoxicillin.$0https://id.nlm.nih.gov/mesh/D000658
650 2 $aClavulanic Acids$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D002969Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aCroydon, E. A. P.$0http://id.loc.gov/authorities/names/n83228045
700 1 $aMichel, M. F.$0http://id.loc.gov/authorities/names/n83228046
830 0 $aCurrent clinical practice series ;$v4.$0http://id.loc.gov/authorities/names/n83742000
852 00 $boff,hsl$hRM666.A49$iA92 1983